Ibiden Co., Ltd. (IBIDEN) financials
JPX · Technology · Hardware, Equipment & Parts · 11,105 employees · CEO Koji Kawashima
- Price
- ¥8,045.00 -3.76%
- Market cap
- ¥4.55T
- Enterprise value
- ¥4.29T
- Last report
- Q2 '27 filed 2026-09-30
- Next report
- 2027-02-04 EPS est. ¥43.54
Valuation & key figures
- Market cap
- ¥4.55T EV ¥4.29T
- Revenue
- ¥483B Trailing 12 months
- Revenue growth
- +33% FY2027 consensus
- Profit margin
- 16.6% Net income / revenue, TTM
- P/E
- 56.2× Forward 51.3× (FY2027)
- P/S
- 9.4× Price / sales, TTM
- EV / EBITDA
- 24.2× TTM
- Free cash flow
- ¥168B Trailing 12 months
- Net income
- ¥80.2B Trailing 12 months
- Revenue estimate
- ¥553B FY2027 consensus
- Earnings
- 2027-02-04 Revenue est. ¥145B
- Dividend
- ¥30.00 Per share, last 12 months
Key takeaways
Computed from the reported numbers - every statement carries the figure it rests on.
- Last report (2026-10-29): revenue beat by 5.5%, EPS missed by 8.7%Revenue ¥140B vs ¥132B expected (+5.5%); EPS ¥36.56 vs ¥40.03 (-8.7%).
- Revenue growth accelerating: 42.1% year on yearQ2 '27 revenue ¥139B, against an average of 16.6% over the four quarters before.
- Operating margin 18.0% (TTM), +5.0 pp on a year agoOperating income grew 74.8% while revenue grew 26.1%.
- 26.7% of pre-tax profit is non-operatingPre-tax income ¥118B vs operating income ¥86.8B (TTM). Gains on equity stakes and other one-off items lift net income and EPS - operating income is the cleaner measure of the business.
- Capex 19.6% of revenue (a year ago 38.8%)¥94.8B invested in the last 4 quarters (-36.3% on a year earlier). Free cash flow ¥168B = 209.5% of net income.
- Returned ¥8.41B to shareholders = 5.0% of free cash flowBuybacks ¥19M (a year earlier ¥639M), dividends ¥8.39B, stock-based pay ¥0 (TTM).
- Diluted share count up 0.2% in a year595M diluted shares in Q2 '27, 594M a year earlier.
- Net cash ¥258BCash + short-term investments ¥420B, debt incl. leases ¥162B; a year ago net cash ¥22.7B.
Last quarter: Q2 '27
Quarter ended 2026-09-30. Compared with the same quarter a year earlier and with the analyst consensus before the report.
Quarter vs a year ago
| Q2 '27 | Year ago | Change | |
|---|---|---|---|
| Revenue | ¥139B | ¥98B | +42.1% |
| Gross margin | 37.9% | 32.5% | +5.4 pp |
| Operating income | ¥33.2B | ¥14B | +137.9% |
| Operating margin | 23.9% | 14.3% | +9.6 pp |
| Net income | ¥20.7B | ¥9.34B | +121.2% |
| Diluted EPS | ¥34.72 | ¥15.74 | +120.7% |
| Operating cash flow | ¥97.3B | ¥27.1B | +258.5% |
| Capex | ¥32.6B | ¥36.3B | -10.4% |
| Free cash flow | ¥64.7B | -¥9.2B | +803.4% |
| R&D | ¥0 | ¥0 | – |
| Stock-based compensation | ¥0 | ¥0 | – |
Reported vs consensus
2026-10-29| Actual | Consensus | vs consensus | |
|---|---|---|---|
| Revenue | ¥140B | ¥132B | +5.5% |
| EPS (as estimated) | ¥36.56 | ¥40.03 | -8.7% |
From the report of 2026-10-29 for Q2 '27: revenue and the EPS analysts estimate (often adjusted), so it can differ from the EPS of the statements above.
EPS vs consensus
last 8 reportsRevenue
Where the money comes from - by business line and by region, quarter by quarter.
Revenue, operating income and growth
quarterlyMargins & cost structure
How much of each unit of revenue is left at each level - and where the costs go.
Margins
quarterlyCosts as % of revenue
quarterlyCash flow & capital allocation
Cash generated, what it is spent on, and what reaches shareholders.
Operating cash flow, capex, free cash flow
quarterlyUses of cash vs operating cash flow
fiscal yearsLast 4 quarters
cash flow statement- Operating cash flow
- ¥263B
- Capex
- -¥94.8B
- Buybacks
- -¥19M
- Dividends
- -¥8.39B
- Acquisitions
- ¥1.1B
- Net debt issued
- -¥69B
- Stock-based compensation
- ¥0
- Free cash flow
- ¥168B
- Returned to shareholders / FCF
- 5.0%
Share count and EPS
quarterly, dilutedBalance sheet
Liquidity, investments and debt at each quarter end.
Cash, investments and debt
quarter endsValuation & returns
Today's multiples against the company's own last five fiscal years; analyst targets and ratings.
Multiples and returns
TTM vs 5 fiscal years| Now | 5y average | Where today sits in the 5-year range | |
|---|---|---|---|
| P/E (TTM) | 56.2× | 22.5× | 14.1× – 32.3× |
| EV / EBITDA | 24.2× | 7.8× | 4.8× – 12.3× |
| EV / Sales | 8.9× | 2.4× | 1.4× – 4.7× |
| Price / FCF | 27.1× | 1,797.7× 4 of 5 years | 15.2× – 7,123.1× |
| Price / Book | 7.5× | 2.2× | 1.1× – 3.7× |
| FCF yield | 3.7% | 0.1% | -14.1% – 6.6% |
| Return on invested capital | 7.6% | 5.8% | 3.5% – 9.0% |
| Return on equity | 14.1% | 9.7% | 6.4% – 12.4% |
Outlook
Analyst consensus for the coming fiscal years and what it implies at today's price.
Consensus estimates
| Fiscal year | Revenue | Growth | EPS | Growth | P/E at today's price | Analysts (EPS) |
|---|---|---|---|---|---|---|
| FY2027 | ¥553B | +32.9% | ¥156.86 | +46.0% | 51.3× | 15 |
| FY2028 | ¥698B | +26.2% | ¥232.55 | +48.2% | 34.6× | 17 |
| FY2029 | ¥884B | +26.6% | ¥332.38 | +42.9% | 24.2× | 15 |
| FY2030 | ¥1.01T | +14.1% | ¥414.85 | +24.8% | 19.4× | 6 |
| FY2031 | ¥1.16T | +14.8% | ¥486.30 | +17.2% | 16.5× | 7 |
Financial statements
Every line of the income statement, balance sheet and cash flow statement - 12 quarters and 10 fiscal years, as values, as % of revenue or as growth.
Sources
Statements, segment revenue, metrics and estimates are standardised from the company's filings.
Data as of 2026-11-02